Abstract:Transfusion therapy is currently an effective therapeutic intervention in a number of diseases, including sickle cell disease. However, its use is complicated by a high incidence of red blood cell (RBC) alloimmunization in the transfusion recipients. The identification of T regulatory cells (Tregs) among the CD4(+)CD25(+) T cell subset as key regulators of peripheral tolerance in mice as well as humans has opened an exciting era in the prevention and treatment of autoimmune disease and for improving organ transplantation. However, their potential In inducing transfusion tolerance remains to be explored. We used red cells from mice transgenic for human glycophorin A blood group antigen as donor cells and transfused wild-type mice to induce alloantibodies, as an experimental system to study RBC alloimmunization. We found that depletion with anti-CD25 enhanced the alloantibody production, indicating that CD25 Tregs play an important role in regulation of alloantibody responses. More importantly, adoptive transfer of purified population of CD4(+)CD25(+) but not CD4(+)CD25(-) cells from naive mice prevented the induction of IgG and IgM alloantibody production in transfusion recipients, with a concomitant reduction in activated splenic B cells and macrophages. Similarly, adoptive transfer of purified populations of CD4(+)CD25(+) cells from naive mice into naive syngeneic recipients inhibited the anti-Ig response to rat RBCs in the recipients but transfer of control CD4(+)CD25(-) cells did not. Altogether, our results demonstrate that Tregs participate in the control of transfusion-associated RBC alloantibody responses, opening up the possibility that Treg immunotherapy may be exploited for suppressing transfusion immunization events.

The Effects of Antibody Treatment on Regulatory CD4+CD25+ T Cells

Regulatory T Cell Therapy for the Induction of Clinical Organ Transplantation Tolerance

Effects of Anti‐CD45RB Monoclonal Antibody for T Lymphocyte Subsets in Mice Heart Transplantation Model

Antibody-induced transplantation tolerance that is dependent on thymus-derived regulatory T cells.

CD4+CD25+ regulatory T cell therapy for the induction of donor-specific clinical transplantation tolerance.

Progress Toward Antibody-Induced Transplantation Tolerance

Role and mechanisms of CD4+CD25+ regulatory T cells in the induction and maintenance of transplantation tolerance.

Regulatory T cells and transplantation tolerance.

CD3-specific antibody-induced active tolerance: from bench to bedside

Regulating Regulatory T Cells to Achieve Transplant Tolerance.

T regulatory cells as an immunotherapy for transplantation.

Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models.

T Regulatory Cells As an Immunotherapy for Transplantation

B cells with regulatory properties in transplantation tolerance

Regulatory-B Cell and Regulatory-T Cell Collaborate to Promote Transplantation Tolerance (126.2)

Human Tregs Made Antigen Specific by Gene Modification: The Power to Treat Autoimmunity and Antidrug Antibodies with Precision

Depleting Anti-Cd4 Monoclonal Antibody (GK1.5) Treatment: Influence on Regulatory CD4+CD25+Foxp3+ T Cells in Mice.

In Vivo Attenuation of Antibody-Mediated Acute Renal Allograft Rejection by Ex Vivo TGF-β-Induced CD4+Foxp3+ Regulatory T Cells

Anti-CD(45)RB Monoclonal Antibody Induces Immunologic Toleration by Suppressing Dendritic Cells.

An Unexpected Counter‐Regulatory Role of IL‐10 in B‐Lymphocyte‐Mediated Transplantation Tolerance

Anti-CD3 Therapy Promotes Tolerance by Selectively Depleting Pathogenic Cells while Preserving Regulatory T Cells